ArticleInternational journal of clinical oncology2018

Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study.

Hironaga Satake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.